FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charles Geyer

Research Profile

Concepts & Ideas

Disorders

Chemicals & Drugs

Procedures

Infusions, Intravenous

Anatomy

Leukocytes, Mononuclear

Co-author Network

Publications

TOP 3
Chia-Chi Lin; Muralidhar Beeram; Eric K Rowinsky; Chris H Takimoto; Chee M Ng; Charles E Geyer; Louis J Denis; Johann S de Bono; Desiree Hao; Anthony W Tolcher; Sun-Young Rha; Jacques Jolivet; Amita Patnaik
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
Mitchell Garrison; Lisa A Hammond; Charles E Geyer; Garry Schwartz; Anthony W Tolcher; Leslie Ann Smetzer; Jose A Figueroa; Murray Ducharme; John Coyle; Chris H Takimoto; Robert L De Jager; Eric K Rowinsky
A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies.
Anthony W Tolcher; S L Gerson; Louis Denis; Charles E Geyer; Lisa A Hammond; Amita Patnaik; A D Goetz; Garry Schwartz; T Edwards; Larisa Reyderman; Paul Statkevich; David L Cutler; Eric K Rowinsky
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charles Geyer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Chia-Chi Lin; Muralidhar Beeram; Eric K Rowinsky; Chris H Takimoto; Chee M Ng; Charles E Geyer; Louis J Denis; Johann S de Bono; Desiree Hao; Anthony W Tolcher; Sun-Young Rha; Jacques Jolivet; Amita Patnaik
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
Cancer chemotherapy and pharmacology 2009;65(1):167-75.
2003: Mitchell Garrison; Lisa A Hammond; Charles E Geyer; Garry Schwartz; Anthony W Tolcher; Leslie Ann Smetzer; Jose A Figueroa; Murray Ducharme; John Coyle; Chris H Takimoto; Robert L De Jager; Eric K Rowinsky
A Phase I and pharmocokinetic study of exatecan mesylate administered as a protracted 21-day infusion in patients with advanced solid malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2527-37.
2003: Anthony W Tolcher; S L Gerson; Louis Denis; Charles E Geyer; Lisa A Hammond; Amita Patnaik; A D Goetz; Garry Schwartz; T Edwards; Larisa Reyderman; Paul Statkevich; David L Cutler; Eric K Rowinsky
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules.
British journal of cancer 2003;88(7):1004-11.
2000: Eric K Rowinsky; T R Johnson; Charles E Geyer; Lisa A Hammond; S Gail Eckhardt; Ronald L Drengler; Leslie Ann Smetzer; John Coyle; Jinee Rizzo; Garry Schwartz; Anthony W Tolcher; Daniel Von Hoff; Robert L De Jager
DX-8951f, a hexacyclic camptothecin analog, on a daily-times-five schedule: a phase I and pharmacokinetic study in patients with advanced solid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(17):3151-63.